Methodological Issues in Study of Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes
JAMA Oncol
.
2023 Feb 1;9(2):281-282.
doi: 10.1001/jamaoncol.2022.6822.
Authors
Yin Zhang
1
,
Edward L Giovannucci
1
2
Affiliations
1
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
2
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
PMID:
36580300
DOI:
10.1001/jamaoncol.2022.6822
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 1* / complications
Diabetes Mellitus, Type 1* / drug therapy
Humans
Insulin / adverse effects
Neoplasms* / drug therapy
Neoplasms* / epidemiology
Risk
Substances
Insulin